罕见病-话题@MedSci

#罕见病#

72篇内容 | 8602人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=602441, encodeId=77b060244184, content=<a href='/topic/show?id=5a8be955621' target=_blank style='color:#2F92EE;'>#罕见病#</a>mark，Still病, objectTitle=FDA批准Still病的首款药物：诺华的白细胞介素-1单抗canakinumab, objectType=article, longId=196063, objectId=e34d196063ce, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200617/cd979518bbac4a0faa9eeed103391b13.jpg, objectUrl=/article/show_article.do?id=e34d196063ce, replyNumber=0, likeNumber=211, createdTime=2020-06-17, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e34d196063ce, moduleTitle=FDA批准Still病的首款药物：诺华的白细胞介素-1单抗canakinumab, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e34d196063ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601728, encodeId=0fe8601e285f, content=<a href='/topic/show?id=5a8be955621' target=_blank style='color:#2F92EE;'>#罕见病#</a>很多罕见病在国内都是大量患者群体, objectTitle=盘点——那些越来越不罕见的“罕见病”, objectType=article, longId=194978, objectId=990a1949e844, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200529/6736c64791e84354b9a3f87b5bdebacf.jpg, objectUrl=/article/show_article.do?id=990a1949e844, replyNumber=0, likeNumber=213, createdTime=2020-06-07, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=990a1949e844, moduleTitle=盘点——那些越来越不罕见的“罕见病”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=990a1949e844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601727, encodeId=b502601e2795, content=<a href='/topic/show?id=5a8be955621' target=_blank style='color:#2F92EE;'>#罕见病#</a>有潜力, objectTitle=FDA授予AAV基因疗法PBGM01"孤儿药"称号，治疗婴儿GM1神经节苷脂贮积症, objectType=article, longId=192750, objectId=788f192e507d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/adhd_children_s20_adhd_symptoms.jpg, objectUrl=/article/show_article.do?id=788f192e507d, replyNumber=0, likeNumber=201, createdTime=2020-06-07, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788f192e507d, moduleTitle=FDA授予AAV基因疗法PBGM01"孤儿药"称号，治疗婴儿GM1神经节苷脂贮积症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=788f192e507d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

罕见病

2020-05-29

lovetcm (审核中...)

前往app查看评论内容

#罕见病#mark，Still病

FDA批准Still病的首款药物：诺华的白细胞介素-1单抗canakinumab

2020-06-17

lovetcm (审核中...)

前往app查看评论内容

#罕见病#很多罕见病在国内都是大量患者群体

盘点——那些越来越不罕见的“罕见病”

2020-06-07

lovetcm (审核中...)

前往app查看评论内容

#罕见病#有潜力

FDA授予AAV基因疗法PBGM01"孤儿药"称号，治疗婴儿GM1神经节苷脂贮积症

2020-06-07

科室
- - 订阅+
  - 更多科室
工具
服务